baber/WOPTO huggingface dataset:
Patent CA-3026944-A1 (CA)
Inventor: LACATUS CONSTANTIN
IPC: H04W40/00
Filed: 2018-12-07
Abstract: Various embodiments are described herein for a radio frequency (RF) signal router. In one example embodiment, the RF router comprises a controller, an input stage, an intermediate stage and an output stage. The input stage includes RF input terminals, pre-processing circuit and input processors, where each RF input terminal receives an incoming RF signal, each pre-processing circuit processes the incoming RF signal based on its power level, and each input processor adjusts a power level of an input RF signal based on a first controller signal to generate a processed input RF signal. The intermediate stage comprises intermediate switch matrices coupled to a controller and input processors, and configured to route intermediate RF signals. The output stage comprises output processors coupled to the controller, where each output processor is configured to adjust a power level of an output RF signal based on a second controller signal and generate a processed output RF signal, and where the second controller signal corresponds to the first controller signal.
Patent CA-3028650-A1 (CA)
Title: Blade mounting and removal tool, system, and product slicer
Inventor: MCGUFFIN-NOLL DOUGLAS
IPC: B26D7/26
Filed: 2017-02-03
Abstract: A blade mounting and removal tool, and system, for safely removing a blade from a food product slicer.
Patent CA-3031705-A1 (CA)
Title: Methodes de traitement du cancer de la prostate
Inventor: GOTTARDIS MARCO
IPC: A61P35/00
Filed: 2017-07-28
Abstract: L'invention porte sur des méthodes de traitement du cancer de la prostate par administration de niraparib à un sujet en ayant besoin.
Patent CA-3036704-A1 (CA)
Title: Methods and systems for screening candidate compounds for their potential to cause systemic or hepatic toxicity
Inventor: BROUWER KENNETH R
IPC: G01N33/58
Filed: 2017-09-18
Abstract: Methods of screening a compound for susceptibility to causing systemic or hepatic toxicity, using a hepatic cell system exposed to a range of concentrations of a bile acid in the absence or presence of a compound to determine a toxicity profile. In vitro systems for predicting in vivo hepatotoxic potential of a compound are also provided, and include in vitro cultured hepatic cell systems with a capacity for bile acid synthesis, bile acid transport and bile acid regulation.
Patent CA-3040682-A1 (CA)
Inventor: DIETZ WILLIAM HENRY
IPC: H01R13/627
Filed: 2017-10-03
Abstract: A latch assembly is provided in a receptacle in a pin-and- sleeve type electrical connector used to capture a plug of the pin-and- sleeve electrical connector. The latch assembly has a housing with a cover, a plurality of latches and a corresponding plurality of latch lever arm extending from a latch lever, such that pivotable movement of the latch lever is translated to rotational movement of the latches between a plug capture position and a plug release position.
Patent CA-3042608-A1 (CA)
Title: Element de renforcement pour augmenter la resistance de materiaux pateux auto-solidifiant
Inventor: CZINTOS CSONGOR
IPC: E04C5/07
Filed: 2017-09-25
Abstract: Un élément de renforcement (10) pour augmenter la résistance de matériaux pâteux auto-solidifiant qui est fait de filaments flexibles, qui comprend une partie centrale (12) à partir de laquelle au moins dans trois directions respectives des leviers (11) s'étendent vers l'extérieur et chacun des leviers (11) comprend au moins deux filaments espacés (13), et les leviers (11) ont des extrémités externes constituées par des circuits respectifs (14) réalisés par la flexion du filament (13) dont le levier associé (11) est réalisé, et dans chaque circuit (14) la distance entre les filaments (13) se situe entre les deux fois et vingt cinquièmes fois la taille du filament (13), et les leviers (11) sont agencés de telle sorte que dans tout demi-espace séparé par n'importe quel plan passant à travers la partie centrale (12) au moins l'un des leviers (11) est agencé.
Patent CA-3044041-A1 (CA)
Title: Fiber optic cable having low thermal strain and methods of manufacturing the same
Inventor: BRINGUIER ANNE GERMAINE
IPC: H01B7/17
Filed: 2017-11-15
Abstract: A polymer composition is provided. The polymer composition includes a polyolefin, at least 30% by weight of a thermoplastic elastomer, and a filler material. When the polymer composition is formed into an article having a longitudinal axis, the polymer composition has an average coefficient of thermal expansion along a longitudinal axis of less than or equal to 150x10-6m/mK as measured from -40C to 25C. Further, the polymer composition has an elastic modulus of less than 3000 MPa as measured using dynamic mechanical analysis (ASTM D4065), and the polymer composition has an elongation at break of greater than 200% along the longitudinal axis (measured according to ASTM D638). An article made from the polymer composition and a cable including the polymer composition are also provided.
Patent CA-3045728-A1 (CA)
Inventor: LALUET JEAN-YVES
IPC: E04B9/32
Filed: 2017-12-08
Abstract: The invention relates to a light-emitting acoustic ceiling panel comprising OLED modules and associated ceiling.
Patent CA-3050957-A1 (CA)
Title: Cable transportation system
Inventor: WIESER HARTMUT
IPC: B61B10/02
Filed: 2019-07-30
Abstract: A cable transportation system comprising: a first terminal station; a second terminal station; a plurality of transporting units moved between the terminal stations; at least one supporting cable for supporting the transporting units between the terminal stations; wherein the supporting cable comprises a first end housed inside the first terminal station and a second end housed inside the second terminal station; a first anchor device for anchoring the first end of the supporting cable inside the first terminal station; a second anchor device for anchoring the second end of the supporting cable inside the second terminal station; wherein the anchor devices are configured to selectively block the ends of the supporting cable inside the respective terminal stations and to allow a stepped sliding of the supporting cable between the terminal stations.
Patent CA-3053479-A1 (CA)
Inventor: KARCZEWICZ MARTA
IPC: H04N19/577
Filed: 2018-03-22
Abstract: Techniques related to decoder-side motion vector derivation (DMVD) are described. For example, this disclosure describes techniques related to applying one or more constraints to motion information, such as a motion vector (MV) derived by DMVD, and/or a MV difference between an initial MV and an MV derived by DMVD. When the constraint is applied to the DMVD, in certain examples, only the derived motion information which meets the constraint is regarded as valid motion information. Conditions may be placed on the constraints.
Patent CA-3053752-A1 (CA)
Title: Dispositif de glisse sur neige
Inventor: YI JI HA
IPC: A63C5/048
Filed: 2018-02-21
Abstract: La présente invention concerne un dispositif de glisse sur neige. La présente invention comprend : un premier corps d'extrémité (10) sur lequel une extrémité d'une chaussure (1) est saisie ; un deuxième corps d'extrémité (30) disposé sur le côté opposé du premier corps d'extrémité (10) et sur lequel l'autre extrémité de la chaussure est saisie ; et un corps principal (50) qui est disposé entre le premier corps d'extrémité (10) et le deuxième corps d'extrémité (30) pour raccorder le premier corps d'extrémité (10) au deuxième corps d'extrémité (30), et dans lequel une surface de bord faisant face au sol peut être modifiée et sélectivement utilisée. Dans le dispositif de glisse sur neige selon la présente invention, un bord peut être remplacé par un pont ou une autre surface du corps principal peut être utilisé en tant que bord. Par conséquent, lorsque le bord est usé, le bord peut être remplacé ou une autre surface peut être utilisée.
Patent CA-3054816-A1 (CA)
Inventor: FREEMAN SCOTT
IPC: G01R31/74
Filed: 2018-02-27
Abstract: Communication enabled circuit breakers are described. Methods associated with secure communication between communication enabled circuit breakers and a panel system are described. Additionally, methods for commissioning and decommissioning such communication enabled circuit breakers in the panel system are described. The communication enabled circuit breakers may be paired with a controller and information regarding such breakers can be added to a database.
Patent CA-3055879-A1 (CA)
Inventor: THOMPSON JOSHUA ALLEN
IPC: B01J20/18
Filed: 2018-01-30
Abstract: Methods for removing acid gases from feed gas: - A method for removing acid gas from feed gas, comprising alternating input of feed gas between beds of adsorbent particles that comprise zeolite SSZ-98 or SSZ-105; wherein gas contacts one of the beds during an adsorption and tail gas is vented from another bed by desorption; wherein a product gas containing no greater than about 2 mol% carbon dioxide is produced, and methane and ethane are recovered. - A process for removing acid gas from feed gas, comprising adjusting selectivity of an adsorbent by changing a substitution of ERI phase with LEV phase in an intergrown molecular sieve. - A process for removing acid gas from a feed gas, comprising: contacting a feed gas with adsorbent comprising a molecular sieve having a defined intergrowth of an ERI phase and a LEV phase.
Patent CA-3056240-A1 (CA)
Title: Utilisation d'inhibiteurs d'ape1/ref-1 dans des polytherapies pour le traitement du cancer
Inventor: KELLEY MARK R
IPC: A61K31/4741
Filed: 2018-03-20
Abstract: L'invention concerne des polythérapies comprenant un inhibiteur spécifique du facteur 1 d'oxydo-réduction (redox)/endonucléase/apurinique/apyrimidinique (APE1/Ref-1) pour inhiber la fonction redox de APE1/Ref-1. Les polythérapies, selon l'invention peuvent être utilisées pour traiter divers cancers, ainsi que d'autres maladies induites par l'angiogenèse (par exemple, des maladies rétiniennes, des maladies cardiovasculaires).
Patent CA-3057558-A1 (CA)
Title: Anticancer combination therapy
Inventor: RUDOLPH DOROTHEA
IPC: A61K31/4162
Filed: 2018-04-04
Abstract: The invention describes anti-cancer therapies comprising using an MDM2 inhibitor in combination with a PD-1 antagonist and a LAG-3 antagonist, each as described herein.
Patent CA-3058095-A1 (CA)
Inventor: SRIVASTAVA VIVEK
IPC: C11D3/386
Filed: 2018-04-26
Abstract: La présente invention concerne des variants de mannanase. La présente invention concerne également des polynucléotides codant pour ces variants; des hybrides d'acides nucléiques, des vecteurs et des cellules hôtes comprenant les polynucléotides; et des procédés d'utilisation des variants.
Patent CA-3059041-A1 (CA)
Title: Catalyst roller for gravity-assisted particle flow
Inventor: BEHKISH ARSAM
IPC: B01J8/00
Filed: 2018-03-19
Abstract: Systems and methods are provided for controlling the flow and transport of catalyst particles within a reaction system. The flow of catalyst particles can be managed using a rotating disc or wheel that is configured within a roller volume to allow for control over the rate of catalyst flow while reducing or minimizing attrition of the catalyst particles. This can be achieved in part by maintaining a relationship between the center of the rotating disc, the inlet for catalyst particles to the roller volume, and the top wall of the roller volume so that catalyst particles are not exposed to compressive forces and/or abrasion during rotation of the disc. Additionally or alternately, the disc and roller volume surfaces can be configured to reduce or minimize the potential for catalyst particles to become trapped in "dead space" regions within the roller volume. By using a disc to provide force for transport of particles through the roller volume, the speed of catalyst movement can be controlled at relatively slow catalyst flow rates with a reduced or minimized risk for clogging or plugging within the roller volume.
Patent CA-3065509-A1 (CA)
Title: Optical sensing cable with acoustic lensing or reflecting features
Inventor: FREELAND RILEY SAUNDERS
IPC: G01L1/24
Filed: 2018-05-25
Abstract: A vibration sensing optical fiber cable is provided. The cable includes at least one optical fiber embedded in the cable jacket such that vibrations from the environment are transmitted into the cable jacket to the optical fiber. The cable is configured in a variety of ways, including through spatial arrangement of the sensing fibers, through acoustic impedance matched materials, through internal vibration reflecting structures, and/or through acoustic lens features to enhance sensitivity of the cable for vibration detection/monitoring.
Patent CA-3065559-A1 (CA)
Title: Funeral tray
Inventor: HOUDE JEAN-FRANCOIS
IPC: A61G17/007
Filed: 2019-12-16
Abstract: The funeral tray can have an elongated bottom and an upwardly projecting wall peripheral to the bottom and leading to a raised rim, defining a concave shape sized and configured to receive the body of a deceased person, the upwardly projecting wall and the bottom being integral to one another and made of bio-based material.
Patent CA-3066413-A1 (CA)
Inventor: WILLIAMS ROBERT C
IPC: G06F3/14
Filed: 2007-09-05
Abstract: In embodiments of the present invention improved capabilities are described for producing background separated product images for print and on- line display. An image formation system provides controllable background and foreground lighting of an item to facilitate acquiring images that appear to have no background, a platform for supporting items, cameras configured to acquire both high contrast and high quality images of the item, and automated image processing algorithms for creating item-only images that can be stored in an image library and presented to a user.
Patent CA-3069138-A1 (CA)
Inventor: ALEXANDER MATTHEW
IPC: A61K31/573
Filed: 2018-07-09
Abstract: Provided herein is 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile, or an enantiomer, a mixture of enantiomers, a tautomer, or a pharmaceutically acceptable salt thereof, and methods for treating, preventing or managing multiple myeloma using such compounds. Also provided are pharmaceutical compositions comprising the compounds, and methods of use of the compositions.
Patent CA-3069526-A1 (CA)
Title: Composes pour la reduction de lesions lipotoxiques
Inventor: ANANDAN SAMPATH-KUMAR
IPC: A61K36/74
Filed: 2018-07-12
Abstract: La présente invention concerne de nouveaux inhibiteurs de lipase et des procédés d'utilisation de ceux-ci pour traiter une inflammation, une défaillance de systèmes d'organes multiples, une mort de cellules acineuses pancréatiques nécrotiques, une pancréatite aiguë, un sepsis (par exemple, un sepsis à culture négative), des brûlures et de l'acné. Par exemple, l'invention concerne deux nouveaux inhibiteurs de lipase utiles dans les procédés de l'invention : (I) (II) ou un sel pharmaceutiquement acceptable de ceux-ci.
Patent CA-3070161-A1 (CA)
Inventor: RUDYAN AMIR
IPC: E04B1/66
Filed: 2020-01-29
Abstract: La présente invention porte essentiellement sur un ensemble de membranes détanchéité doubles souterraines sans visibilité intégrant une membrane en feuille avec adhésif pour se lier complètement au béton ou au béton projeté, de même que sur une méthode de fabrication, et sur lutilisation dudit ensemble. Plus précisément, linvention concerne un système de membranes doubles qui agit comme une barrière et qui empêche et bloque leau et lhumidité de passer dun côté à lautre de la structure. Ce système innovant de couche imperméable peut être utilisé le long dun mur, dun plancher, dun plafond ou de toute structure où limperméabilisation est nécessaire. Linvention peut être utilisée de manière très efficace entre une couche de béton ou de béton projeté et le sol environnant, par exemple, le long dune zone présentant une nappe deau près de la surface du sol ou pour empêcher lhumidité du sol ou une pression hydrostatique susceptible de sinfiltrer dans une fondation ou un mur.
Patent CA-3072239-A1 (CA)
Title: Sealing member for prosthetic heart valve
Inventor: LEVI TAMIR S
IPC: A61F2/24
Filed: 2018-08-20
Abstract: An implantable prosthetic valve can comprise an annular frame comprising an inflow end and an outflow end and being radially collapsible and expandable between a radially collapsed configuration and a radially expanded configuration, the frame defining an axial direction extending from the inflow end to the outflow end, a leaflet structure positioned within the frame and secured thereto, and an outer sealing member positioned around an outer surface of the frame, wherein the outer sealing member comprises a plurality of sealing segments, wherein each sealing segment is coupled to the frame and/or another sealing segment by a tether that pulls a portion of the sealing segment in a circumferential direction when the frame is radially expanded to the expanded configuration.
Patent CA-3073112-A1 (CA)
Inventor: BRAJE WILFRIED
IPC: A61P35/00
Filed: 2018-08-15
Abstract: La présente invention concerne des composés de la formule (I), où A2, A3, A4, A6, A7, A8, A15, RA, R5, R9, R10A, R10B, R11, R12, R13, R14, R16, W, X, et Y ont l'une quelconque des valeurs définies dans la description, ainsi que des sels de qualité pharmaceutique de ceux-ci, qui sont utilisables en tant qu'agents dans le traitement de maladies et d'états pathologiques, y compris le cancer. La présente invention concerne en outre des compositions pharmaceutiques comprenant les composés de la formule (I).
Patent CA-3073297-A1 (CA)
Inventor: PEREZ-PERRI JOEL IGNAZIO
IPC: G01N33/53
Filed: 2018-08-17
Abstract: The present invention relates to an improved method of detecting RNA-binding proteins (RBPs) in cells, tissues or organisms, comprising the use of oligonucleotides comprising locked nucleic acid (LNA)-nucleotide analogues in the sequence thereof.
Patent CA-3075630-A1 (CA)
Inventor: SOON-SHIONG PATRICK
IPC: C07K14/705
Filed: 2018-09-28
Abstract: Compositions, methods and uses of genetically modified NKT cells to induce an NKT cell immune response against tumor or to change a microenvironment of the tumor by suppressing an activity of myeloid-derived suppressor cells are presented. In some embodiments, naive NKT cells are obtained from a patient having a tumor, and are genetically engineered to include a chimeric protein, a T cell receptor, a hybrid T cell receptor replacing the endogenous T cell receptor, or one of CD40L and Fas-L. The naive or genetically modified NKT cells can be administered to a cancer patient to trigger and/or boost immune response against the tumor.
Patent CA-3077625-A1 (CA)
Title: Treatment of insects
Inventor: VERHOEVEN MARTINUS JOHANNES WILHELMUS
IPC: A01M1/00
Filed: 2018-10-17
Abstract: The present invention relates to a method to treat insects in order to produce a human nutrition and/or an animal feed. The treatment involves at reducing and preferably stopping the autolysis of the insects, preferably using a cooling treatment step. The present invention further relates to a line to process insects.
Patent CA-3077813-A1 (CA)
Inventor: FISH JASON
IPC: F28D1/047
Filed: 2020-04-01
Abstract: A gas turbine engine includes a fan assembly, a compressor assembly, a combustion chamber, a turbine assembly, a bypass duct conveying rearward a bypass airstream driven by the fan assembly when the gas turbine engine is in use, a fairing extending across at least a portion of the bypass duct downstream of the fan assembly, and a heat exchanger having an inlet fluidly connected to the compressor assembly and an outlet fluidly connected to a pneumatic actuator of the gas turbine engine.  The fairing has a leading edge and a trailing edge. The heat exchanger is disposed adjacent the trailing edge of the fairing.
Patent CA-3078304-A1 (CA)
Inventor: CHEN LAN BO
IPC: C07K16/30
Filed: 2019-03-19
Abstract: An isolated nucleic acid that contains a nucleotide sequence that encodes the polypeptide of SEQ ID NO: 3. The polypeptide of SEQ ID NO: 3 specifically binds to stage-specific embryonic antigen 4 (SSEA4). Also disclosed is a recombinant cell comprising the isolated nucleic acid described above, a viral vector containing the above isolated nucleic acid, and an isolated polypeptide including the sequence of SEQ ID NO: 3. Provided as well is a chimeric antigen receptor (CAR) that includes a single chain Fv having the sequence of SEQ ID NO: 3 and specifically binding to SSEA4. Moreover, a method is disclosed for treating a tumor by transducing in vitro the T cells of a subject having a tumor expressing SSEA4 with a vector that encodes the CAR, expanding the transduced T cells, and infusing the expanded transduced T cells into the subject, whereby an anti-tumor T cell response is raised.
Patent CA-3078605-A1 (CA)
Title: Tim-3 antagonists for the treatment and diagnosis of cancers
Inventor: KLIPPEL ANKE
IPC: A61K39/00
Filed: 2018-08-28
Abstract: Provided herein are methods for treating a subject afflicted with a cancer, comprising administering to the subject a TIM3 agonist (e.g., an anti-TIM3 antibody), alone or in conjunction with another immune checkpoint inhibitor (e.g., a PD-1 antagonist), wherein the subject is identified as having a high frequency of TIM3 positive cells (e.g., on the tumor infiltrating inflammatory cells) or soluble TIM3 in peripheral blood. Also provided are methods for assessing the efficacy of a treatment comprising a TIM3 antagonist in a subject afflicted with a cancer, comprising measuring the frequency of TIM3 (and optionally PD-1) positive cells in certain populations of cells and/or the soluble TIM3 in peripheral blood of the subject, wherein a high frequency of TIM3 (and optionally PD-1) positive cells and/or the subject's peripheral blood titer of soluble TIM3 is indicative of the response to the treatment.
Patent CA-3078895-A1 (CA)
Title: Virtual reticle for augmented reality systems
Inventor: HOOVER PAUL ARMISTEAD
IPC: A63F13/21
Filed: 2018-10-25
Abstract: Systems and methods for displaying a virtual reticle in an augmented or virtual reality environment by a wearable device are described. The environment can include real or virtual objects that may be interacted with by the user through a variety of poses, such as, e.g., head pose, eye pose or gaze, or body pose. The user may select objects by pointing the virtual reticle toward a target object by changing pose or gaze. The wearable device can recognize that an orientation of a user's head or eyes is outside of a range of acceptable or comfortable head or eye poses and accelerate the movement of the reticle away from a default position and toward a position in the direction of the user's head or eye movement, which can reduce the amount of movement by the user to align the reticle and target.
Patent CA-3079317-A1 (CA)
Title: Collapsible grill
Inventor: WILLIAMS DAN
IPC: A47J37/07
Filed: 2020-04-23
Abstract: An embodiment of a support assembly for a grill may include a leg subassembly comprising a first leg and a second leg, a leg subassembly comprising a first leg and a second leg, the first leg defining a retaining aperture, and a rotatable pin collar assembly configured to couple the first leg to the second leg in a slidable and lockable connection, the rotatable pin collar assembly including a spring pin configured to be retained in the retaining aperture at a first longitudinal position on the first leg when the grill is in a standing locked configuration and configured to be positioned at a second longitudinal position on the first leg when the grill is in a collapsed configuration.
Patent CA-3080687-A1 (CA)
Inventor: MANO NICOLAS
IPC: C08L97/00
Filed: 2018-10-16
Abstract: The invention relates to a lignin that is soluble in a medium having a pH of greater than or equal to 4, a solution containing same, a method for producing same and uses thereof, in particular for preparing lignin fibres and carbon fibres. The soluble lignin can be obtained by means of enzymatic modification.